MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive: While, the increasing of Numb expression or the inhibition of Msi2 expression might lead to inhibition of the Notch signaling pathway and direct the cell toward differentiation; therefore, the CML blastic phase is suppressed.